Brilinta is an oral antiplatelet medication used to reduce the risk of cardiovascular events. Its active ingredient clopidogrel works by selectively inhibiting the p2x12 receptor on platelet adp-binding sites. This inhibition prevents adp-mediated activation of the glycoprotein iib/iiia complex, thereby decreasing platelet aggregation. The drug is converted in the liver to an active metabolite that irreversibly binds to the receptor. As a result, the antiplatelet effect persists for the lifespan of affected platelets, which circulate for about a week. Clinically, Brilinta is prescribed to maintain graft patency and improve outcomes in patients undergoing percutaneous coronary intervention.

Brilinta is an oral antiplatelet medication that helps prevent blood clots. It is prescribed to reduce the chance of heart attack or stroke after a recent heart attack or severe chest pain. The drug works by selectively blocking the adp receptor on platelets called p2y12. Blocking this receptor stops platelets from becoming overly sticky. This action reduces platelet aggregation, the process that can block arteries. The active metabolite of Brilinta binds to the p2y12 site and prevents adp from activating the receptor. As a result, the blood flow is maintained more safely in the coronary vessels. Brilinta's therapeutic effect therefore lowers the risk of cardiovascular events in vulnerable patients.

Brilinta may cause shortness of breath and dizziness in some patients. It can increase the risk of bleeding such as bruising or nosebleeds. Some users experience headache or itching at the application site. In rare cases, severe allergic reactions may occur. The medication may affect taste perception or cause fatigue. These effects are generally mild to moderate and often improve over time.

Brilinta may cause bleeding from the gums or nose which can appear as frequent nosebleeds or prolonged gum bleeding. Some people experience dizziness or lightheadedness especially when standing up quickly. Swelling of the ankles or lower legs can occur and may be accompanied by sudden weight gain. Shortness of breath may develop without an obvious cause and should be monitored. Headache and nausea are also reported side effects in certain individuals. Bruising may appear more easily than expected due to the medication effect on platelets. Fatigue or unusual weakness can be noted in some patients during treatment.